Literature DB >> 3504385

Vigabatrin: no microvacuoles in a human brain.

B Pedersen1, K Højgaard, M Dam.   

Abstract

Vigabatrin (gamma-vinyl-GABA) has been shown to be an effective antiepileptic drug. However, clinical investigations have been hampered by the finding of intramyelin edema (microvacuoles) in rats and dogs. In an autopsy study of a 38-year-old woman with astrocytoma, treated with vigabatrin 80 mg/kg body weight per day for over 6 months and 125 mg/kg body weight per day for the last 2 months as add-on therapy because of drug-resistant epilepsy, we did not find any microvacuoles in the brain. So far microvacuoles have never been observed in primates, warranting continued investigations of this promising antiepileptic drug.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3504385     DOI: 10.1016/0920-1211(87)90054-4

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  8 in total

1.  Visual field defects associated with vigabatrin therapy.

Authors:  M C Lawden; T Eke; C Degg; G F Harding; J M Wild
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-12       Impact factor: 10.154

Review 2.  Vigabatrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy and disorders of motor control.

Authors:  S M Grant; R C Heel
Journal:  Drugs       Date:  1991-06       Impact factor: 9.546

3.  Vigabatrin: rational treatment for chronic epilepsy.

Authors:  H A Ring; A J Heller; I N Farr; E H Reynolds
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-12       Impact factor: 10.154

4.  Efficacy and safety of vigabatrin in the long-term treatment of refractory epilepsy.

Authors:  C Remy; D Beaumont
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

5.  Evaluation of vigabatrin as an add-on drug in the management of severe epilepsy.

Authors:  J W Sander; P C Trevisol-Bittencourt; Y M Hart; S D Shorvon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-11       Impact factor: 10.154

6.  Vigabatrin and psychosis.

Authors:  J W Sander; Y M Hart; M R Trimble; S D Shorvon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-05       Impact factor: 10.154

7.  Effects of vigabatrin and of GABA on myelinated rat cerebellar cultures: preliminary data.

Authors:  J J Hauw; J M Boutry; P Sun; V Sazdovitch; C Duyckaerts
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

8.  Effects of vigabatrin on evoked potentials in epileptic patients.

Authors:  V Cosi; R Callieco; C A Galimberti; R Manni; A Tartara; J Mumford; E Perucca
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.